# Teva & Xenon Receive FDA 'Orphan Drug' status for EM treatment candidate

**URL:** https://forum.livingwitherythromelalgia.org/t/teva-xenon-receive-fda-orphan-drug-status-for-em-treatment-candidate/387
**Category:** Articles and Research
**Created:** [April 23, 2013, 8:44pm UTC](https://forum.livingwitherythromelalgia.org/t/teva-xenon-receive-fda-orphan-drug-status-for-em-treatment-candidate/387 "2013-04-23T20:44:30Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![Don\_J](https://yyz1.discourse-cdn.com/flex027/user_avatar/forum.livingwitherythromelalgia.org/don_j/32/7_2.png) [@Don\_J](https://forum.livingwitherythromelalgia.org/u/Don_J)
#### Post date: [April 23, 2013, 8:44pm UTC](https://forum.livingwitherythromelalgia.org/t/teva-xenon-receive-fda-orphan-drug-status-for-em-treatment-candidate/387/1 "2013-04-23T20:44:30Z")

</div>

Teva and Xenon announced that Xenon's erythromelalgia drug in Phase 2 trials has received FDA "Orphan Drug" status.

This means that the companies are eligible to receive various tax deductions as well as some exclusive rights to develop the drug for 7 years.

[http://www.nasdaq.com/article/teva-xenon-pharma-announce-fda-orphan-drug-designation-for-pain-drug-xen402-20130423-00565#.UXbxb7XvumQ](http://www.nasdaq.com/article/teva-xenon-pharma-announce-fda-orphan-drug-designation-for-pain-drug-xen402-20130423-00565#.UXbxb7XvumQ)